Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000482147 | SCV000569899 | likely pathogenic | not provided | 2023-12-22 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation as the last 426 amino acids are lost; This variant is associated with the following publications: (PMID: 31440721, 35982159, 35982160) |
Fulgent Genetics, |
RCV000763447 | SCV000894221 | pathogenic | Developmental and epileptic encephalopathy, 26 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000763447 | SCV000933235 | likely pathogenic | Developmental and epileptic encephalopathy, 26 | 2024-01-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg433*) in the KCNB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 426 amino acid(s) of the KCNB1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with KCNB1-related disease (PMID: 35982159; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 420881). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000763447 | SCV005200881 | pathogenic | Developmental and epileptic encephalopathy, 26 | 2024-06-14 | criteria provided, single submitter | clinical testing | PVS1, PM2, PM6 |
Clinical Genetics Laboratory, |
RCV000763447 | SCV001739348 | pathogenic | Developmental and epileptic encephalopathy, 26 | 2021-05-10 | no assertion criteria provided | clinical testing | |
Génétique des Maladies du Développement, |
RCV000763447 | SCV002104269 | pathogenic | Developmental and epileptic encephalopathy, 26 | no assertion criteria provided | clinical testing |